These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29547430)

  • 1. Access to Medicines for Improving Access to Safe Anesthetic Care.
    Nickerson JW; Chikumba E
    Anesth Analg; 2018 Apr; 126(4):1405-1408. PubMed ID: 29547430
    [No Abstract]   [Full Text] [Related]  

  • 2. Shortages of inexpensive essential medicines.
    Vyas M; de Vries EGE; Casali PG; Tabernero J
    Lancet Oncol; 2019 May; 20(5):e224-e225. PubMed ID: 31006527
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving Anesthesia Safety in Low-Resource Settings.
    Khan FA; Merry AF
    Anesth Analg; 2018 Apr; 126(4):1312-1320. PubMed ID: 29547426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ensuring patient access to essential medicines while minimizing harmful use: a revised World Health Organization tool to improve national drug control policy.
    Gilson AM; Maurer MA; Ryan KM; Skemp-Brown M; Husain A; Cleary JF
    J Pain Palliat Care Pharmacother; 2011; 25(3):246-51. PubMed ID: 21882978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance and problems of the Turkish pharmaceutical industry: is there a need to develop a national drug policy?
    Kisa A
    J Med Syst; 2001 Oct; 25(5):309-18. PubMed ID: 11508904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 7. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 8. Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.
    Bird RC
    J Law Med Ethics; 2009; 37(2):209-21. PubMed ID: 19493067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introductory note: The access to Essential Medicines Campaign.
    Kindermans JM; Matthys F
    Trop Med Int Health; 2001 Nov; 6(11):955-6. PubMed ID: 11703852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug policy: making effective drugs available without bankrupting the healthcare system.
    Laupacis A; Anderson G; O'Brien B
    Healthc Pap; 2002; 3(1):12-30. PubMed ID: 12811107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policies and programs to facilitate access to targeted cancer therapies in Thailand.
    Sruamsiri R; Ross-Degnan D; Lu CY; Chaiyakunapruk N; Wagner AK
    PLoS One; 2015; 10(3):e0119945. PubMed ID: 25798948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 13. Essential medicines twenty-five years on: closing the access gap.
    Quick JD
    Health Policy Plan; 2003 Mar; 18(1):1-3. PubMed ID: 12582103
    [No Abstract]   [Full Text] [Related]  

  • 14. Access to medicines versus access to treatment: the case of type 1 diabetes.
    Beran D; McCabe A; Yudkin JS
    Bull World Health Organ; 2008 Aug; 86(8):648-9. PubMed ID: 18797626
    [No Abstract]   [Full Text] [Related]  

  • 15. Essential Medicines in the United States--Why Access Is Diminishing.
    Alpern JD; Song J; Stauffer WM
    N Engl J Med; 2016 May; 374(20):1904-7. PubMed ID: 27192669
    [No Abstract]   [Full Text] [Related]  

  • 16. Essential medicines out of reach for most people.
    Indian J Med Sci; 2008 Dec; 62(12):520-1. PubMed ID: 19402257
    [No Abstract]   [Full Text] [Related]  

  • 17. Access to Antihypertensive Drugs in China.
    Bai G; Bennet C; Wang J; Anderson GF
    Circulation; 2018 Oct; 138(17):1777-1779. PubMed ID: 30354658
    [No Abstract]   [Full Text] [Related]  

  • 18. No deal in sight on cheap drugs for poor countries.
    Fleck F
    Bull World Health Organ; 2003; 81(4):307-8. PubMed ID: 12764500
    [No Abstract]   [Full Text] [Related]  

  • 19. The silent victims of the US embargo against Iran.
    Ghalibafian M; Hemmati S; Bouffet E
    Lancet Oncol; 2018 Nov; 19(11):e580. PubMed ID: 30507483
    [No Abstract]   [Full Text] [Related]  

  • 20. The crisis in access to essential medicines in India: key issues which call for action.
    Bhargava A; Kalantri SP
    Indian J Med Ethics; 2013; 10(2):86-95. PubMed ID: 23697486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.